Instituto Condal de Oftalmologia
- Address
- C/ Vía Augusta, 48-54, 2º, 08006 Barcelona, Spain
Instituto Condal de Oftalmologia - Dry Eye and Ocular Surface Disorders Center
Instituto Condal de Oftalmologia is a specialized ophthalmological research center dedicated to advancing the understanding and treatment of ocular surface diseases. The institute demonstrates particular expertise in dry eye disease management and meibomian gland dysfunction, focusing on innovative therapeutic approaches that combine medical devices with pharmacological interventions.
- Dry eye disease (DED) associated with meibomian gland dysfunction
- Novel topical treatments and medical device evaluation
- Ocular inflammatory biomarker research
The center's research methodology integrates comprehensive clinical outcome assessments with inflammatory cytokine analysis in tears, providing insights into the pathophysiology of dry eye conditions. Their clinical trials emphasize safety monitoring, particularly regarding intraocular pressure changes, while evaluating both symptom scores and objective clinical signs. This approach reflects a commitment to developing evidence-based treatments for meibomian gland dysfunction that address both patient comfort and underlying inflammatory mechanisms.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instituto Condal de Oftalmologia
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Hydrocortisone Sodium Phosphate in Dry Eye Disease with Moderate Meibomian Gland Dysfunction: A Randomized Controlled Trial | Laboratorios Thea S.A. | Phase III | Not Recruiting | Oct 2021 | Jul 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Hydrocortisone Sodium Phosphate | 1 | Unknown | 2021-10-26 | 2021-10-26 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.